Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation
Clinical trial NCT02138786 · TERMINATED
Trial details
- NCT number
- NCT02138786
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-14
- Primary completion
- 2016-08-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.